Top 10 Evidence-Based Essentials in Family Medicine

• by Conexiant News Staff

• May 27, 2026

FDA Expands Bladder Cancer Regimen

KEYNOTE-B15/EV-304 demonstrated statistically significant improvements in event-free and overall survival with perioperative pembrolizumab plus enfortumab vedotin-ejfv compared with neoadjuvant gemcitabine plus cisplatin.

• by Kathryn Wighton

• July 10, 2026

• 2 min

PERMA-based mobile psychological intervention with and without telephone support for university students: study protocol for a randomized controlled trial

• by Vanessa Blanco, Fataneh Sinaeipour, Queila Bouza, Fernando L. Vázquez

• July 9, 2026

Self-Sampling Shows Test Agreement

The study authors frame the device as a potential way to simplify screening, while emphasizing that larger validation studies are still needed.

• by Andrea Surnit

• July 8, 2026

• 5 min